A Phase 3 Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-naïve Patients With Premenopausal Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

167

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Premenopausal Breast Cancer
Interventions
DRUG

TAP-144-SR(6M)

DRUG

TAP-144-SR(3M)

Trial Locations (15)

Unknown

Nagoya

Fukushima

Maebashi

Ohta-shi

Sapporo

Isehara-shi

Yokohama

Kumamoto

Kyoto

Nigata-shi

Kurashiki-shi

Osaka

Suita-shi

Kita-adachi-gun

Shinjuku-ku

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY

NCT01546649 - A Phase 3 Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-naïve Patients With Premenopausal Breast Cancer | Biotech Hunter | Biotech Hunter